Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J9130 |
Short Description | Dacarbazine 100 mg inj |
Long Description | Dacarbazine, 100 mg |
Pricing indicator | 51 |
Coverage code | D |
ASC payment group code | |
BETOS2 code | O1D |
Action code | N |
Type of service | 1 |
Effective date | 2004-01-01 |
Date Added | 1986-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
00143924510 | J9130 | Dacarbazine 100 mg inj | Dacarbazine | HIKMA PHARMACEUTICALS USA INC. | 100 MG | 1 | 10 | 2 | 20 |
00703507501 | J9130 | Dacarbazine 100 mg inj | Dacarbazine | SICOR PHARMACEUTICALS, INC. | 100 MG | 1 | 1 | 2 | 2 |
00703507503 | J9130 | Dacarbazine 100 mg inj | Dacarbazine | SICOR PHARMACEUTICALS, INC. | 100 MG | 1 | 10 | 2 | 20 |
63323012710 | J9130 | Dacarbazine 100 mg inj | Dacarbazine | FRESENIUS KABI | 100 MG | 1 | 10 | 1 | 10 |
63323012820 | J9130 | Dacarbazine 100 mg inj | Dacarbazine | FRESENIUS KABI | 100 MG | 1 | 10 | 2 | 20 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 100 MG |
HCPCS/CPT Billing Units | 0.01 |
Total doses ordered | |
Billing Units | 0.01 |
Drug Details
-
Dacarbazine is used to treat melanoma (a type of skin cancer) that has spread to other parts of your body. Dacarbazine is also used in combination with other medications to treat Hodgkin's lymphoma (Hodgkin's disease; a type of cancer that begins in a type of white blood cells that normally fights infection). Dacarbazine is in a class of medications known as purine analogs. It works by slowing or stopping the growth of cancer cells in your body.